Premium
HNF1α controls renal glucose reabsorption in mouse and man
Author(s) -
Pontoglio Marco,
Prié Dominique,
Cheret Claire,
Doyen Antonia,
Leroy Christine,
Froguel Philippe,
Velho Gilberto,
Yaniv Moshe,
Friedlander Gérard
Publication year - 2000
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.1093/embo-reports/kvd071
Subject(s) - hepatocyte nuclear factors , endocrinology , medicine , renal glucose reabsorption , reabsorption , biology , kidney , glucose homeostasis , maturity onset diabetes of the young , diabetes mellitus , urinary system , gene expression , type 2 diabetes , gene , genetics , insulin resistance
Recently it has been shown that dominant mutations in the human hepatocyte nuclear factor 1 α (HNF1α) gene, encoding for a homeoprotein that is expressed in liver, kidney, pancreas and intestine, result in maturity onset diabetes of the young type 3 (MODY3). HNF1α‐null mice are diabetic, but at the same time suffer from a renal Fanconi syndrome characterized by urinary glucose loss. Here we show that MODY3 patients are also characterized by a reduced tubular reabsorption of glucose. The renal murine defect is due to reduced expression of the low affinity/high capacity glucose cotransporter (SGLT2). Our results show that HNF1α directly controls SGLT2 gene expression. Together these data indicate that HNF1α plays a key role in glucose homeostasis in mammals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom